Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)
U.S. Jobless Claims Jump to an Eight-Week High
32:46 - First-time filings for unemployment benefits grew more than expected for the past week, increasing to an eight-week high of 282,000. Bloomberg's Vonnie Quinn reports on "Market Makers." (Source: Bloomberg)
  • Fed Rate Hike: A Change of Plans?
  • China's Xi Reducing Military by 300,000 Soldiers
  • The Top 5 Business News Stories to Watch for Today